Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]

Underlying metabolic pathways in cancer

Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain

Underlying metabolic pathways in cancer ( Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain )

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain

Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )

Signaling and targeting cellular pathways in leukaemia metabolism

Dr Jing Chen – Emory University School of Medicine, Atlanta, USA

Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )

Whole genome sequence analysis for acute lymphoblastic leukaemia

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA

Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )

Use of mesenchymal stromal cells against graft-versus-host disease

Prof Willem Fibbe – Lieden University Medical Center, Holland

Use of mesenchymal stromal cells against graft-versus-host disease ( Prof Willem Fibbe – Lieden University Medical Center, Holland )

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK

Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium

Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )

PI3K and the heterogeneity of small tumour breast cancer

Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium

PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )

Heterogeneity of tumours and the challenges of biomarker development

Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy

Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )

Targeting the cancer genome

Dr Bill Sellers - Novartis Institutes for Biomedical Research, Cambridge...

Targeting the cancer genome ( Dr Bill Sellers - Novartis Institutes for Biomedical Research, Cambridge, Massachusetts )

Anti-angiogenic agents and cancer stem cells

Dr Max Wicha - University of Michigan, Ann Arbor, USA

Anti-angiogenic agents and cancer stem cells ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )

More from ecancer